Phc Holdings Corp. · TSE:6523
Phc — Investor Presentation (May 2026)
35 slides from Phc's investor presentation, May 2026
Slide 1: Introduction to PHC Group
Introduction to PHC Group PHC Holdings Corporation
Slide 2: Contents
Contents 1 PHC Group Overview P.03 4 Business Domains P.12 Diabetes Management P.13 P.17 2 Our History P.06 Healthcare Solutions P.19 P.21 P.24 Diagnostics & Life Sciences P.26 ©PHC Holdings Corporation 2026 3 Mission／Vision／Values P.08 5 Sustainability P.32 2
Slide 3: PHC Group Overview
1 PHC Group Overview ©PHC Holdings Corporation 2026 Overview History Mission／Vision／Values Diabetes Management Healthcare Solutions Diagnostics & Life Sciences Sustainability 3
Slide 4: PHC Group Overview
PHC Group Overview Company PHC Holdings Corporation Name 15F DAI-ICHI LIFE HIBIYA FIRST Business Address/ 1-13-2 Yurakucho, Chiyoda-ku, Head Office Tokyo 100-8403, Japan Founded 1969 (Founded as Matsushita Kotobuki Electronics Co., Ltd.) President, Representative Director and CEO Representative Kyok
Slide 5: PHC Group Highlights
PHC Group Highlights PHC Group is a global network of healthcare companies dedicated to improving health through digital and precision technology. Since our founding in Japan in 1969, we have been driving better health through solutions in diagnostics, life sciences, diabetes management, and health
Slide 6: Our History
2 Our History ©PHC Holdings Corporation 2026 Overview History Mission／Vision／Values Diabetes Management Healthcare Solutions Diagnostics & Life Sciences Sustainability 6
Slide 7: PHC Group History
PHC Group History PHC Holdings Corporation listed on the First Section Wemex of the Tokyo Stock Corporation*2 Acquisition of anatomical Exchange*1 begins operations pathology business from Thermo Fisher Scientific, Acquisition of diabetes Inc. to establish Epredia care business from Bayer Holdings L
Slide 8: Mission／Vision／Values
3 Mission／Vision／Values ©PHC Holdings Corporation 2026 Overview History Mission／Vision／Values Diabetes Management Healthcare Solutions Diagnostics & Life Sciences Sustainability 8
Slide 9: Mission／Vision／Values
Mission／Vision／Values We contribute to the health of society through our diligent efforts to create healthcare solutions that have a positive impact and improve the lives of people. Be a leader in precision technology that powers the future of healthcare. Curiosity ©PHC Holdings Corporation 2026 Cou
Slide 10: PHC Group Business Domains
PHC Group Business Domains Diabetes Management Healthcare Solutions Diagnostics & Life Sciences Healthcare IT Clinical Testing CRO Diabetes Management Business Unit Solutions Pathology Business Unit Life Sciences Business Unit Business Unit Business Unit Business Unit • Clinical Testing • Anatomical
Slide 11: Global Network
Global Network Our global business includes 80 subsidiaries, with sales in more than 125 countries and regions. * * JAPAN* • Manufacturing Sites (Including R&D Sites) ／13 • Sales Sites ／123 ©PHC Holdings Corporation 2026 • Testing Laboratories ／35 PHC Corporation PHC Corporation R&D/manufacturing si
Slide 12: Business Domains
4 Business Domains ©PHC Holdings Corporation 2026 Overview History Mission／Vision／Values Diabetes Management Healthcare Solutions Diagnostics & Life Sciences Sustainability 12
Slide 13: Overview (Ascensia Diabetes Care)
Overview Ascensia Diabetes Care is a global leader in diabetes technology. We have been entirely dedicated to improving the health and lives of people with diabetes for over 80 years. Our Strengths Target Customers Serving people with diabetes in more than 90 People with 1 countries and regions Diab
Slide 14: Main Products and Services
Main Products and Services Our blood glucose monitoring systems are highly accurate, easy-to-use, and widely accepted by people with diabetes around the world. Ascensia offers solutions to effectively manage diabetes while leveraging monitored data through the integration of digital technology. Bloo
Slide 15: Diabetes Management OEM Partnerships
DIABETES MANAGEMENT OEM PARTNERSHIPS PHC Corporation serves as an Original Equipment Manufacturer (OEM), supplying strategic partners in Japan with technology to contribute to the detection, monitoring, and treatment of diabetes. Blood Glucose Blood Glucose Lancing Devices/ Monitoring System History
Slide 16: Diabetes Management Global Network
Diabetes Management Global Network Manufacturing sites in Indonesia and Japan, and operations in more than 30 countries and regions. …Countries/regions involved in Diabetes Management business (not including distributors’ offices) ©PHC Holdings Corporation 2026 • Ascensia Diabetes Care Holdings AG (
Slide 17: Overview (LSI Medience)
Overview Since the founding of its predecessor, Medical Science Corporation, in 1975, the business that is now LSI Medience has contributed to the prevention, early detection, and treatment of diseases through clinical testing. Our Strengths Target Customers Diverse testing portfolio with more than
Slide 18: Main Products and Services
Main Products and Services LSI Medience provides services in clinical testing through laboratory analysis, including cancer diagnostics, genetic testing, and sports doping testing. Clinical Testing Doping Tests Its Laboratory Automation System responds to advanced clinical Support global anti-doping
Slide 19: Overview (Wemex)
Overview Wemex is a healthcare solution provider that contributes to the digital transformation of healthcare. The business has a long history of providing cutting-edge healthcare IT for clinics and pharmacies in Japan, starting with launching Japan's first receipt computer in 1972. Our Strengths Ta
Slide 20: Main Products and Services
Main Products and Services Wemex advances digital transformation in healthcare in Japan by pioneering innovation-driven solutions and promoting the Japanese government's medical policies. Through initiatives such as streamlining operations in clinics, hospitals, pharmacies, and dental clinics, as we
Slide 21: Overview (Mediford)
Overview Mediford was established in 2023, integrating the clinical trial business previously under LSI Medience Corporation and the non- clinical testing business formerly under LSIM Safety Science Institute Corporation. Our Strengths Target Customers Broad range of services from non-clinical testi
Slide 22: Main Products and Services
Main Products and Services Mediford offers services that support a wide range of research and development, from the exploratory phase of drug development to clinical testing, using reliable testing and analytical capabilities accumulated through extensive experience in contract research. Non-clinica
Slide 23: Healthcare Solutions Network in Japan
Healthcare Solutions Network in Japan R&D, manufacturing, laboratory, and sales sites across Japan Headquarters Headquarters Headquarters （Itabashi-ku, Tokyo） （Shibuya-ku, Tokyo） （Itabashi-ku, Tokyo） • Itabashi/Tokyo • Tokyo • Itabashi/Tokyo R&D or • Saitama • Ibaraki Manufacturing • Nagano • Kumamo
Slide 24: Overview (Epredia)
Overview Epredia is a global leader in anatomical pathology, working to improve patient outcomes by providing a comprehensive range of solutions supporting precision cancer diagnostics and research. Every second of every day, 48 Epredia products are used in the battle against cancer. Our Strengths T
Slide 25: Main Products and Services
Main Products and Services From instruments to microscope slides and staining reagents, Epredia's diagnostic solutions help to improve workflow efficiency from specimen collection to analysis. Together they enable safer, quicker, and more accurate diagnoses of cancer. Histology Laser Slide Printers
Slide 26: Overview (Life Sciences)
Overview In our Life Sciences business, we provide value to life sciences research and medical practice through advanced technological expertise and manufacturing excellence with high precision. Our diverse product lineup includes indispensable research and medical support equipment for long-term bi
Slide 27: Main Products and Services
Main Products and Services Through three segments of solutions in life science, pharmacy, and food catering, we create new values in life science research and medical practice. Pharmaceutical Refrigerators with Ultra-Low Temperature Freezers CO2 Incubators IoT Lab Management Solution Freezer / Pharm
Slide 28: Main Products and Services
Main Products and Services PHC Corporation contributes to real-time testing in medical practices through its highly accurate diagnostic reagents, developed from the industry's first latex technology, and its compact POCT (point of care testing) devices. Diagnostic Reagents Diagnostic Instruments His
Slide 29: Life Sciences OEM Partnerships
LIFE SCIENCES OEM PARTNERSHIPS We collaborate with partners to contribute to the detection and treatment of disease. Motorized Digital Injector Motorized Digital Injector Motorized Digital Injector Supplied to JCR Pharmaceuticals Supplied to Pfizer Inc. Supplied to Teijin Pharma Limited Co., Ltd. PO
Slide 30: Diagnostics & Life Sciences Global Network
Diagnostics & Life Sciences Global Network Manufacturing facilities in Europe, the U.S., and Asia. Sales offices in 14 countries for Epredia and eight countries for PHC. Epredia Holdings Ltd. Headquarters (U.S.) …Headquarters of Group Companies …Manufacturing Sites …Sales Sites …R&D ©PHC Holdings Co
Slide 31: Diagnostics & Life Sciences Network in Japan
Diagnostics & Life Sciences Network in Japan Sales Sites • Tokyo • Osaka • Fukuoka …Headquarters of Group Companies …Manufacturing Sites Sales Sites • Hokkaido • Aichi … Sales Sites • Miyagi • Osaka …R&D • Tokyo • Hiroshima (Headquarters) • Fukuoka • Kanagawa Manufacturing Sites • Chiba（Narita Plan
Slide 32: Sustainability
5 Sustainability ©PHC Holdings Corporation 2026 Overview History Mission／Vision／Values Diabetes Management Healthcare Solutions Diagnostics & Life Sciences Sustainability 32
Slide 33: Sustainability
Sustainability Environment Social Governance We aim to become carbon neutral by 2040. This will By providing high-quality, cutting-edge products, we We will ensure the trust of our stakeholders through be achieved through our materiality topics. contribute to the development of new treatments compli
Slide 34: Participation in sustainability initiatives / Rating
Sustainability Participation in Rating sustainability initiatives Near-term Science Based Targets Disclosed our environmental Earned the Bonze Medal in Selected as a constituent of the Validated By Global Organization information through CDP*2 EcoVadis' Sustainability Assessment*3 MSCI Japan Equity
Slide 35: Published in May 2026
PHc GROUP Published in May 2026